The report “Transplant Diagnostics Market by Technology (Serological, SSO- & SSP-PCR, Sanger Sequencing, NGS), Product (Instrument, Reagent, Software), End User (Hospitals, Transplant Centers, Academia), Application (Diagnostic, Research) - Global Forecasts to 2019”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
The global transplant diagnostics market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $645.0 Million in 2019
The global transplant diagnostics market is further classified into three end user segments, namely hospitals and transplant centers, research laboratories and academic institutes, and commercial service providers. Additionally, the global transplant diagnostics market is segmented based on applications into diagnostic applications and research applications.
A number of factors such as growing geriatric population, coupled with an increasing population base for chronic disease patients, technological advancement in the field of HLA typing, increased public-private investments to develop innovative HLA testing products, rising number of solid organ, soft tissue, and stem cell-based transplantation procedures across the world, and growth in robot-assisted laboratory automation of diagnostic procedures are fuelling the growth of the global transplant diagnostics market. On the other hand, high cost of PCR and NGS instruments and limited medical reimbursements available for transplantation procedure across the globe are some of the key factors hampering the market growth.
As of 2014, North America holds the largest share of the transplant diagnostics market, followed by Europe. However, the Asia-Pacific market is expected to grow at highest CAGR during 2014 to 2019. A number of factors such as increasing focus of global life science companies in emerging markets, growing public and private support to develop novel HLA typing technologies, and strengthening healthcare infrastructure across the APAC are stimulating the growth of the transplant diagnostics market in the Asia-Pacific region.
Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), Illumina, Inc. (U.S.), Immucor, Inc. (U.S.), Linkage Biosciences (U.S.), Olerup Ssp Ab (Norway), Qiagen N.V. (Netherlands), Sigma-Aldrich (U.S.), and Thermo Fisher Scientific Inc. (U.S.) are the major players in the global transplant diagnostics market.
MarketsandMarkets (marketsandmarkets.com) is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform,"RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.